EE200200570A - Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon - Google Patents

Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon

Info

Publication number
EE200200570A
EE200200570A EEP200200570A EEP200200570A EE200200570A EE 200200570 A EE200200570 A EE 200200570A EE P200200570 A EEP200200570 A EE P200200570A EE P200200570 A EEP200200570 A EE P200200570A EE 200200570 A EE200200570 A EE 200200570A
Authority
EE
Estonia
Prior art keywords
blocker
cholesterol
beta
lowering agent
new combination
Prior art date
Application number
EEP200200570A
Other languages
English (en)
Estonian (et)
Inventor
Bondjers G�ran
Wiklund Olov
Wikstrand John
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0001188A external-priority patent/SE0001188D0/xx
Priority claimed from SE0002352A external-priority patent/SE0002352D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200570A publication Critical patent/EE200200570A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200200570A 2000-04-03 2001-03-27 Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon EE200200570A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0001188A SE0001188D0 (sv) 2000-04-03 2000-04-03 New combination
SE0002352A SE0002352D0 (sv) 2000-06-22 2000-06-22 New combination
PCT/SE2001/000663 WO2001074394A1 (en) 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent

Publications (1)

Publication Number Publication Date
EE200200570A true EE200200570A (et) 2004-04-15

Family

ID=26655059

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200570A EE200200570A (et) 2000-04-03 2001-03-27 Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon

Country Status (25)

Country Link
US (2) US20030060477A1 (de)
EP (1) EP1272219B1 (de)
JP (1) JP2003528928A (de)
KR (1) KR20020086749A (de)
CN (1) CN1422161A (de)
AR (1) AR030414A1 (de)
AT (1) ATE347909T1 (de)
AU (2) AU4298501A (de)
BR (1) BR0109753A (de)
CA (1) CA2403160A1 (de)
DE (1) DE60125159T2 (de)
EE (1) EE200200570A (de)
ES (1) ES2276774T3 (de)
HK (1) HK1051325A1 (de)
HU (1) HUP0300332A3 (de)
IL (1) IL151589A0 (de)
IS (1) IS6554A (de)
MX (1) MXPA02009705A (de)
MY (1) MY136386A (de)
NO (1) NO20024732D0 (de)
NZ (1) NZ521351A (de)
PL (1) PL357813A1 (de)
RU (1) RU2002123591A (de)
SK (1) SK14102002A3 (de)
WO (1) WO2001074394A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790197B2 (en) 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
ITMI20040145A1 (it) * 2004-01-30 2004-04-30 Acraf L-moprololo lpiu' tartrato
EP1722758A1 (de) * 2004-02-11 2006-11-22 Athpharma Limited Chronotherapeutische zusammensetzungen und anwendungsverfahren dafür
EP1771413B1 (de) * 2004-05-03 2011-09-21 Janssen Pharmaceutica NV Benzofuranderivate als selektive androgenrezeptormodulatoren (sarms)
CN101022791B (zh) * 2004-06-04 2011-11-16 麦兰实验室公司 含奈必洛尔的组合物
CN101534825A (zh) 2006-08-04 2009-09-16 Aska制药株式会社 含有贝特类药物的制剂及其制备方法
GB0624282D0 (en) * 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
KR20100045344A (ko) * 2008-10-23 2010-05-03 한올바이오파마주식회사 방출성이 제어된 베타 아드레날린 차단제와 ＨＭＧ-ＣｏＡ 환원 효소 억제제의 신규 복합 조성물
MX344885B (es) * 2008-11-10 2017-01-10 Psicofarma S A De C V Proceso para la obtencion de una composicion de rosuvastatina calcica y producto obtenido.
CN102462844A (zh) * 2010-11-05 2012-05-23 四川滇虹医药开发有限公司 一种替利洛尔的药物组合物及其制备方法
WO2013157833A1 (ko) * 2012-04-18 2013-10-24 서울대학교산학협력단 베타-차단제를 유효성분으로 포함하는 비만, 비만으로 인한 대사성 질환 및 골감소증 예방, 개선 또는 치료용 조성물
CN103613586B (zh) * 2013-11-01 2016-06-08 北京博爱旺康医药科技有限公司 一种旋光纯s-(-)-阿罗洛尔酸式盐及其制备方法和应用
CN103626750B (zh) * 2013-11-15 2016-02-24 北京博爱旺康医药科技有限公司 一种盐酸阿罗洛尔及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) * 1989-03-06 1995-10-03 Baligadoo; Soorianarain Synergistic compositions of amiodarone and beta blockers
ATE141049T1 (de) * 1991-03-18 1996-08-15 Sepracor Inc Zubereitung und verfahren enthaltend optisch reines s-metoprolol
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
NO177455C (no) * 1993-06-04 1995-09-20 Gerrit Elmenhorst Anordning ved apparat for fremstilling av brannslukkende skum
AU732465B2 (en) * 1996-04-17 2001-04-26 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
SE9602762D0 (sv) * 1996-07-12 1996-07-12 Astra Ab Carton and blank for forming the same
US5998458A (en) * 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
DE69911058T2 (de) * 1998-12-23 2004-06-03 G.D. Searle Llc, Chicago Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen

Also Published As

Publication number Publication date
HUP0300332A2 (hu) 2003-06-28
CA2403160A1 (en) 2001-10-11
NZ521351A (en) 2004-08-27
CN1422161A (zh) 2003-06-04
NO20024732L (no) 2002-10-02
EP1272219B1 (de) 2006-12-13
AU4298501A (en) 2001-10-15
DE60125159T2 (de) 2007-10-25
AR030414A1 (es) 2003-08-20
HK1051325A1 (en) 2003-08-01
JP2003528928A (ja) 2003-09-30
NO20024732D0 (no) 2002-10-02
ATE347909T1 (de) 2007-01-15
MY136386A (en) 2008-09-30
SK14102002A3 (sk) 2003-06-03
IS6554A (is) 2002-09-19
ES2276774T3 (es) 2007-07-01
WO2001074394A8 (en) 2002-05-23
IL151589A0 (en) 2003-04-10
US20030060477A1 (en) 2003-03-27
AU2001242985B2 (en) 2005-02-24
EP1272219A1 (de) 2003-01-08
HUP0300332A3 (en) 2005-03-29
RU2002123591A (ru) 2004-03-20
MXPA02009705A (es) 2004-02-26
US20040192784A1 (en) 2004-09-30
DE60125159D1 (de) 2007-01-25
KR20020086749A (ko) 2002-11-18
PL357813A1 (en) 2004-07-26
WO2001074394A1 (en) 2001-10-11
BR0109753A (pt) 2003-02-04

Similar Documents

Publication Publication Date Title
EE200200570A (et) Uus beeta-blokaatori ja kolesterooli alandava aine kombinatsioon
DE60132052D1 (de) Bohr- und Behandlungsflüssigkeiten
NO20023616D0 (no) Ny anvendelse
CY2012009I1 (el) Αναστολεις της κυκλοπροπυλ-συντηκωμενης διπεπτυλοπεπτιδασης 4, βασισμενοι σε πυρρολιδινη, και μεθοδοι για την παρασκευη των και την χρηση των
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
ATE269701T1 (de) Gyrase-inhibitoren und ihre verwendung
DE60201461D1 (de) Arbeitsgerät, dessen Benutzer hinterher läuft
PT1326853E (pt) Novos tiadiazoles e oxadiazoles e sua utilizacao como inibidores da fosfodiesterase-7
ATE340786T1 (de) Salze eines 4-isothiazolcarboxamids und ihre verwendung als anti-hyperproliferationsmittel
ATE314280T1 (de) Karton und kartonzuschnitt
EE200200620A (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud ateroskleroosi ravimiseks ja/või ennetamiseks
DE10196021T1 (de) Universeller Vermögenswert- und Beziehungsmanager
AU2001242985A1 (en) New combination of a betablocker and a cholesterol-lowering agent
ID30464A (id) Pakaian luar sekali pakai untuk operasi pembedahan
IS5996A (is) Notkun á kólesteról lækkandi miðli
DE60113623D1 (de) Wässrige Emulsion und wässrige Beschichtungsmittel
FI20001477A (fi) Influenssavirusta sitova aine ja sen käyttö
EE200200703A (et) Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm
EE200000394A (et) Lokaalanesteetikumide uus kasutamine vaskulaarsete peavalude vastu
NO20031369L (no) Kalium-kanal interagerende forbindelser, og anvendelser derav
AU2001234180A1 (en) Benzamide derivative and use thereof
ZA200207107B (en) New combination of a betablocker and a cholesterol-lowering agent.
NO20023243D0 (no) Ny terapeutisk anvendelse av enoxaparin
FR2837847B1 (fr) Textile enduit et expanse
FI991397A0 (fi) Petun uusi käyttö